Nevertheless the identification of this liver derived circulating factor potentially involved in the regulation of glucose and lipid metabolism triggered a great research interest in this hormone as potential therapeutic target or new biomarker for the metabolic syndrome, leading to several clinical studies examining the role of betatrophin in humans with multiple pathological conditions. Here, ANGPTL8 is linked to metabolic syndrome.